Interest rate expected to rise by end of May

By JPOST STAFF, AP
May 11, 2006 04:15

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Israeli banking officials expected the key interest rate to rise by the end of May, following the US Federal Reserve's decision to raise the key interest rate to the highest level in more than five years, Army Radio reported. The Fed boosted its target for the federal funds rate to five percent. The funds rate, the interest that banks charge each other, stood at a 46-year low of one percent when the central bank began raising rates in June 2004 to keep inflation under control. In its statement announcing the decision, US central bank policy-makers indicated they may take at least a brief pause in hiking rates. It said the "extent and timing" of further rate increases would depend on future economic data.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS